# OnCo record parp-plus-bevacizumab (pairing). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/pairings/parp-plus-bevacizumab/>
  a schema:MedicalTherapy ;
  onco:kind "pairing" ;
  schema:identifier "parp-plus-bevacizumab" ;
  schema:name "PARP inhibitor + bevacizumab maintenance (HRD-positive)"@en ;
  schema:description "In tumours with faulty DNA repair, adding olaparib to bevacizumab maintenance roughly doubled progression-free time and improved survival."@en ;
  schema:url <https://onco.cc/pairings/parp-plus-bevacizumab/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02477644> ;
  onco:cancers <https://onco.cc/cancers/ovarian/> ;
  onco:targets <https://onco.cc/targets/parp/>, <https://onco.cc/targets/vegf/> ;
  onco:terms <https://onco.cc/terms/hrd/> ;
  onco:trials <https://onco.cc/trials/paola-1/> ;
  onco:pairs <https://onco.cc/drugs/olaparib/>, <https://onco.cc/drugs/bevacizumab/> .